Jun. 09, 2022
Vermilion Therapeutics Inc., University of Tokyo, and Wakayama Medical Univ. has received the “Special Award of Cutting-Edge Technology”
“Cutting-Edge Technology Award”: Today, we are pleased to announce that the R&D team of Vermilion Therapeutics Inc., University of Tokyo, and Wakayama Medical University has received the “Special Award of Cutting-Edge Technology” from Ministry of Education, Culture, Sports, Science and Technology (MEXT), and Ministry of Economy, Trade and Industry (METI) and Fuji–Sankei group.
https://www.sankei.com/article/20220609-GX3QHEI4VRN3ZCJ4GNS2HDIWOM/